Company profile: VitaLink Research
1.1 - Company Overview
Company description
- Provider of clinical trial research site services conducting Phase II-IV clinical trials for pharmaceutical companies and contract research organizations, evaluating the efficacy and safety of new treatments and interventions.
Products and services
- Phase III Clinical Trials: Delivers sponsor-contracted studies at clinical research sites to test efficacy and safety of new treatments and interventions for pharmaceutical companies and contract research organizations
- Phase II Clinical Trials: Offers site-based studies evaluating efficacy and safety of new treatments and interventions for pharmaceutical companies and contract research organizations
- Phase IV Clinical Trials: Runs interventional studies assessing efficacy and safety of new treatments and interventions for pharmaceutical companies and contract research organizations at clinical research sites
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to VitaLink Research
Yuhan
HQ: United States
Website
- Description: Provider of business development and partnership services in the pharmaceutical industry, focusing on exploring collaborative opportunities in targeted therapy, oncology immunotherapy, and metabolic diseases as the U.S. subsidiary of Yuhan Corporation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Yuhan company profile →
Premier Research
HQ: United Kingdom
Website
- Description: Provider of clinical trial and regulatory services for biopharmaceutical and medical device companies, including clinical operations (site selection, patient enrollment), project management and delivery, data management and biostatistics, medical and regulatory affairs (EU MDR compliance, clinical evaluation), functional services (biometrics, regulatory support), and records management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Premier Research company profile →
Inamed
HQ: Germany
Website
- Description: Provider of aerosol biophysics and technology with more than 30 years of experience.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inamed company profile →
Euticals
HQ: Italy
Website
- Description: Provider of active pharmaceutical ingredients (APIs), custom synthesis, and fine chemicals. A leading player in the pharmaceutical and fine chemicals industry, with global-scale production, diversified manufacturing plants, and multiple technologies, delivering projects and products in fine chemicals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Euticals company profile →
Bachem
HQ: Switzerland
Website
- Description: Provider of full-service biochemicals to the pharma and biotech industry; an independent, technology-based company specializing in process development and GMP manufacturing of peptide and oligonucleotide APIs, complex organic molecules, and innovative research biochemicals. Offers research-grade and GMP peptides, oligonucleotide NCE development, commercial APIs and generics, catalog peptides, custom peptide synthesis, amino acid derivatives, and products for diagnostics and cosmetics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bachem company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for VitaLink Research
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to VitaLink Research
2.2 - Growth funds investing in similar companies to VitaLink Research
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for VitaLink Research
4.2 - Public trading comparable groups for VitaLink Research
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →